Clinical Trial Update: Ticin Pilot Study: Sirolimus-Eluting Balloon for Stabilization and Regression of Non-Obstructive Coronary Plaques. [NA]

View source ↗

Summary

Pilot study evaluating a sirolimus-eluting balloon to stabilize and regress non-obstructive coronary plaques; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Coronary Syndromes
• Multivessel Coronary Artery Disease

Drugs mentioned

• Sirolimus-eluting balloon (sirolimus)

Snippet

Sponsor: Cardiocentro Ticino | Conditions: Coronary Arterial Disease (CAD), Vulnerable Coronary Plaques | NA | Status: NOT_YET_RECRUITING